Stabilization of the Trigonal High-Temperature Phase of Formamidinium Lead Iodide
Binek, Andreas, Hanusch, Fabian C, Docampo, Pablo, Bein, Thomas
Published in The journal of physical chemistry letters (02.04.2015)
Published in The journal of physical chemistry letters (02.04.2015)
Get full text
Journal Article
Synchronized Offset Stacking: A Concept for Growing Large-Domain and Highly Crystalline 2D Covalent Organic Frameworks
Auras, Florian, Ascherl, Laura, Hakimioun, Amir H, Margraf, Johannes T, Hanusch, Fabian C, Reuter, Stephan, Bessinger, Derya, Döblinger, Markus, Hettstedt, Christina, Karaghiosoff, Konstantin, Herbert, Simon, Knochel, Paul, Clark, Timothy, Bein, Thomas
Published in Journal of the American Chemical Society (28.12.2016)
Published in Journal of the American Chemical Society (28.12.2016)
Get full text
Journal Article
A randomised phase II study investigating durvalumab in addition to an anthracycline taxane-based neoadjuvant therapy in early triple-negative breast cancer: clinical results and biomarker analysis of GeparNuevo study
Loibl, S., Untch, M., Burchardi, N., Huober, J., Sinn, B.V., Blohmer, J.-U., Grischke, E.-M., Furlanetto, J., Tesch, H., Hanusch, C., Engels, K., Rezai, M., Jackisch, C., Schmitt, W.D., von Minckwitz, G., Thomalla, J., Kümmel, S., Rautenberg, B., Fasching, P.A., Weber, K., Rhiem, K., Denkert, C., Schneeweiss, A.
Published in Annals of oncology (01.08.2019)
Published in Annals of oncology (01.08.2019)
Get full text
Journal Article
Efficient Planar Heterojunction Perovskite Solar Cells Based on Formamidinium Lead Bromide
Hanusch, Fabian C, Wiesenmayer, Erwin, Mankel, Eric, Binek, Andreas, Angloher, Philipp, Fraunhofer, Christina, Giesbrecht, Nadja, Feckl, Johann M, Jaegermann, Wolfram, Johrendt, Dirk, Bein, Thomas, Docampo, Pablo
Published in The journal of physical chemistry letters (21.08.2014)
Published in The journal of physical chemistry letters (21.08.2014)
Get full text
Journal Article
Neoadjuvant durvalumab improves survival in early triple-negative breast cancer independent of pathological complete response
Loibl, S., Schneeweiss, A., Huober, J., Braun, M., Rey, J., Blohmer, J.-U., Furlanetto, J., Zahm, D.-M., Hanusch, C., Thomalla, J., Jackisch, C., Staib, P., Link, T., Rhiem, K., Solbach, C., Fasching, P.A., Nekljudova, V., Denkert, C., Untch, M.
Published in Annals of oncology (01.11.2022)
Published in Annals of oncology (01.11.2022)
Get full text
Journal Article
Neoadjuvant paclitaxel/olaparib in comparison to paclitaxel/carboplatinum in patients with HER2-negative breast cancer and homologous recombination deficiency (GeparOLA study)
Fasching, P.A., Link, T., Hauke, J., Seither, F., Jackisch, C., Klare, P., Schmatloch, S., Hanusch, C., Huober, J., Stefek, A., Seiler, S., Schmitt, W.D., Uleer, C., Doering, G., Rhiem, K., Schneeweiss, A., Engels, K., Denkert, C., Schmutzler, R.K., Hahnen, E., Untch, M., Burchardi, N., Blohmer, J.-U., Loibl, S.
Published in Annals of oncology (01.01.2021)
Published in Annals of oncology (01.01.2021)
Get full text
Journal Article
Tumor mutational burden and immune infiltration as independent predictors of response to neoadjuvant immune checkpoint inhibition in early TNBC in GeparNuevo
Karn, T., Denkert, C., Weber, K.E., Holtrich, U., Hanusch, C., Sinn, B.V., Higgs, B.W., Jank, P., Sinn, H.P., Huober, J., Becker, C., Blohmer, J.-U., Marmé, F., Schmitt, W.D., Wu, S., van Mackelenbergh, M., Müller, V., Schem, C., Stickeler, E., Fasching, P.A., Jackisch, C., Untch, M., Schneeweiss, A., Loibl, S.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
Dual HER2-blockade with pertuzumab and trastuzumab in HER2-positive early breast cancer: a subanalysis of data from the randomized phase III GeparSepto trial
Loibl, S., Jackisch, C., Schneeweiss, A., Schmatloch, S., Aktas, B., Denkert, C., Wiebringhaus, H., Kümmel, S., Warm, M., Paepke, S., Just, M., Hanusch, C., Hackmann, J., Blohmer, J.-U., Clemens, M., Dan Costa, S., Gerber, B., Engels, K., Nekljudova, V., von Minckwitz, G., Untch, M.
Published in Annals of oncology (01.03.2017)
Published in Annals of oncology (01.03.2017)
Get full text
Journal Article
Neoadjuvant bevacizumab and anthracycline-taxane-based chemotherapy in 678 triple-negative primary breast cancers; results from the geparquinto study (GBG 44)
GERBER, B, LOIBL, S, KREIENBERG, R, SOLBACH, C, JACKISCH, C, KUNZ, G, BLOHMER, J. U, HUOBER, J, HAUSCHILD, M, NEKLJUDOVA, V, UNTCH, M, VON MINCKWITZ, G, EIDTMANN, H, REZAI, M, FASCHING, P. A, TESCH, H, EGGEMANN, H, SCHRADER, I, KITTEL, K, HANUSCH, C
Published in Annals of oncology (01.12.2013)
Published in Annals of oncology (01.12.2013)
Get full text
Journal Article
Effect of Alendronic Acid on Fracture Healing: A Multicenter Randomized Placebo‐Controlled Trial
Duckworth, Andrew D, McQueen, Margaret M, Tuck, Christopher E, Tobias, Jonathan H, Wilkinson, Jeremy Mark, Biant, Leela C, Pulford, Elizabeth Claire, Aldridge, Stephen, Edwards, Claire, Roberts, Chris P, Ramachandran, Manoj, McAndrew, Andrew Richard, Cheng, Kenneth CK, Johnston, Phillip, Shah, Nasir H, Mathew, Philip, Harvie, John, Hanusch, Birgit C, Harkess, Ronnie, Rodriguez, Aryelly, Murray, Gordon D, Ralston, Stuart H
Published in Journal of bone and mineral research (01.06.2019)
Published in Journal of bone and mineral research (01.06.2019)
Get full text
Journal Article
Survival after adding capecitabine and trastuzumab to neoadjuvant anthracycline-taxane-based chemotherapy for primary breast cancer (GBG 40—GeparQuattro)
von Minckwitz, G., Rezai, M., Fasching, P.A., Huober, J., Tesch, H., Bauerfeind, I., Hilfrich, J., Eidtmann, H., Gerber, B., Hanusch, C., Blohmer, J.U., Costa, S.D., Jackisch, C., Paepke, S., Schneeweiss, A., Kümmel, S., Denkert, C., Mehta, K., Loibl, S., Untch, M.
Published in Annals of oncology (01.01.2014)
Published in Annals of oncology (01.01.2014)
Get full text
Journal Article
Congruence and trajectories of device-measured and self-reported physical activity during therapy for early breast cancer
Helbrich, H., Braun, M., Hanusch, C., Mueller, G., Falk, H., Flondor, R., Harbeck, N., Hermelink, K., Wuerstlein, R., Keim, S., Neufeld, F., Steins-Loeber, S., Haertl, K.
Published in Breast cancer research and treatment (01.07.2021)
Published in Breast cancer research and treatment (01.07.2021)
Get full text
Journal Article
Corrigendum to “A randomised phase II study investigating durvalumab in addition to an anthracycline taxane-based neoadjuvant therapy in early triple-negative breast cancer: clinical results and biomarker analysis of GeparNuevo study”: [Annals of Oncology (2019), volume 30:1279-1288]
Loibl, S., Untch, M., Burchardi, N., Huober, J., Sinn, B.V., Blohmer, J.-U., Grischke, E.-M., Furlanetto, J., Tesch, H., Hanusch, C., Engels, K., Rezai, M., Jackisch, C., Schmitt, W.D., von Minckwitz, G., Thomalla, J., Kümmel, S., Rautenberg, B., Fasching, P.A., Weber, K., Rhiem, K., Denkert, C., Schneeweiss, A.
Published in Annals of oncology (01.07.2022)
Published in Annals of oncology (01.07.2022)
Get full text
Journal Article
Quantitative Computed Tomography (QCT) of the Distal Forearm in Men Using a Spiral Whole-Body CT Scanner - Description of a Method and Reliability Assessment of the QCT Pro Software
Hanusch, Birgit C, Tuck, Stephen P, Mekkayil, Babitha, Shawgi, Mohamed, McNally, Richard J Q, Walker, Julie, Francis, Roger M, Datta, Harish K
Published in Journal of clinical densitometry (01.07.2020)
Published in Journal of clinical densitometry (01.07.2020)
Get more information
Journal Article
Zoledronate for patients with invasive residual disease after anthracyclines-taxane-based chemotherapy for early breast cancer – The Phase III NeoAdjuvant Trial Add-oN (NaTaN) study (GBG 36/ABCSG 29)
von Minckwitz, G, Rezai, M, Tesch, H, Huober, J, Gerber, B, Zahm, D.M, Hilfrich, J, Costa, S.D, Dubsky, P, Blohmer, J.U, Denkert, C, Hanusch, C, Jackisch, C, Kümmel, S, Fasching, P.A, Schneeweiss, A, Paepke, S, Untch, M, Burchardi, N, Mehta, K, Loibl, S
Published in European journal of cancer (1990) (01.09.2016)
Published in European journal of cancer (1990) (01.09.2016)
Get full text
Journal Article
Phase IB study of the EpCAM antibody adecatumumab combined with docetaxel in patients with EpCAM-positive relapsed or refractory advanced-stage breast cancer
Schmidt, M., Rüttinger, D., Sebastian, M., Hanusch, C.A., Marschner, N., Baeuerle, P.A., Wolf, A., Göppel, G., Oruzio, D., Schlimok, G., Steger, G.G., Wolf, C., Eiermann, W., Lang, A., Schuler, M.
Published in Annals of oncology (01.09.2012)
Published in Annals of oncology (01.09.2012)
Get full text
Journal Article
Factors predicting relapse in early breast cancer patients with a pathological complete response after neoadjuvant therapy: Pooled analysis based on the GBG database
Huober, J., Schneeweiss, A., Blohmer, J.-U., Denkert, C., Hanusch, C., Jackisch, C., Nekljudova, V., Seither, F., Loibl, S., Untch, M.
Published in Annals of oncology (01.05.2019)
Published in Annals of oncology (01.05.2019)
Get full text
Journal Article
Impact of nab-paclitaxel dose reduction on survival of the randomized phase III GeparSepto trial comparing neoadjuvant chemotherapy of weekly nab-paclitaxel (nP) with solvent-based paclitaxel (P) followed by anthracycline/cyclophosphamide for patients with early breast cancer (BC)
Untch, M., Jackisch, C., Schneeweiss, A., Schmatloch, S., Aktas, B., Denkert, C., Schem, C., Wiebringhaus, H., Kümmel, S., Rhiem, K., Warm, M., Fasching, P.A., Just, M., Hanusch, C., Hackmann, J., Blohmer, J.-U., Furlanetto, J., Nekljudova, V., von Minckwitz, G., Loibl, S.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Germline mutation status and therapy response in patients with triple-negative breast cancer (TNBC): Results of the GeparOcto study
Pohl, E., Schneeweiss, A., Hauke, J., Moebus, V., Furlanetto, J., Denkert, C., Fasching, P.A., Hanusch, C., Tesch, H., Weber-Lassalle, N., Müller, V., Rhiem, K., Untch, M., Luebbe, K., Lederer, B., Jackisch, C., Nekljudova, V., Schmutzler, R.K., Hahnen, E., Loibl, S.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Integrating bevacizumab, everolimus, and lapatinib into current neoadjuvant chemotherapy regimen for primary breast cancer. Safety results of the GeparQuinto trial
von Minckwitz, G., Eidtmann, H., Loibl, S., Blohmer, J.-U., Costa, S.-D., Fasching, P.A., Kreienberg, R., Hilfrich, J., Gerber, B., Hanusch, C., Fehm, T., Strumberg, D., Solbach, C., Nekljudova, V., Untch, M.
Published in Annals of oncology (01.02.2011)
Published in Annals of oncology (01.02.2011)
Get full text
Journal Article